Collects samples and data from people with amyloid diseases
Stores blood, urine and tissue samples from adults with amyloid diseases for future study.
Key facts
- Who runs it
- Boston Medical Center
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- Jan 2000
- Expected to end
- Dec 2040
- Type of study
- Observational
- Treatments tested
- clonality analysis
- polymerase chain reaction
- protein analysis
- biologic sample preservation procedure
- laboratory biomarker analysis
- fluorescence spectroscopy
- quality-of-life assessment
- Record updated
- 1 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have amyloidosis or may have it, and who were referred to the Amyloid Treatment and Research Center at Boston University Medical Center. Samples and data are collected for future research.
- Age
- 18 Years and older
- Sex
- Men and women
- Disease stage
- Diagnosis or suspicion of amyloidosis
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- DISEASE CHARACTERISTICS:
- Diagnosis or suspicion of amyloidosis; PATIENT CHARACTERISTICS:
- Referred to the Amyloid Treatment and Research Center at Boston University Medical Center; PRIOR CONCURRENT THERAPY:
- Not specified
Who cannot take part
- None
Where in United States
- Boston University Cancer Research CenterBoston, United StatesContact: Clinical Trials Office - Boston University Cancer Research CenTaking people
About the trial
What the trial wants to find out
RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future.
Read full original descriptionShow less
PURPOSE: This research study is collecting samples from patients with amyloid diseases
Treatments tested
- clonality analysis
- polymerase chain reaction
- protein analysis
- biologic sample preservation procedure
- laboratory biomarker analysis
- fluorescence spectroscopy
- quality-of-life assessment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Data, Tissue, Blood, and Urine Repository for Amyloid Diseases
- Plain-language title
- Collects samples and data from people with amyloid diseasesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- The Amyloidosis Intersection: Dual Amyloid Types in a Single Host.European journal of haematology, 2025
- Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis.Blood advances, 2020
- A new era of amyloidosis: the trends at a major US referral centre.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2019
- Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis.Blood, 2019
- Record updated
- 1 December 2025